Fiboman

NEktar R/S lines and a gap that needs to close

NASDAQ:NKTR   Nektar Therapeutics
.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.